CN107821923A - The preparation method of microcapsules containing lycopene - Google Patents
The preparation method of microcapsules containing lycopene Download PDFInfo
- Publication number
- CN107821923A CN107821923A CN201711211478.9A CN201711211478A CN107821923A CN 107821923 A CN107821923 A CN 107821923A CN 201711211478 A CN201711211478 A CN 201711211478A CN 107821923 A CN107821923 A CN 107821923A
- Authority
- CN
- China
- Prior art keywords
- lycopene
- mixed
- oil
- core
- ganoderma lucidum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000012661 lycopene Nutrition 0.000 title claims abstract description 41
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 title claims abstract description 35
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 title claims abstract description 35
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 title claims abstract description 35
- 239000001751 lycopene Substances 0.000 title claims abstract description 35
- 229960004999 lycopene Drugs 0.000 title claims abstract description 35
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 title claims abstract description 35
- 239000003094 microcapsule Substances 0.000 title claims abstract description 22
- 238000002360 preparation method Methods 0.000 title claims abstract description 7
- 239000000463 material Substances 0.000 claims abstract description 21
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 21
- 235000019198 oils Nutrition 0.000 claims abstract description 18
- 240000008397 Ganoderma lucidum Species 0.000 claims abstract description 17
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims abstract description 17
- 150000001875 compounds Chemical class 0.000 claims abstract description 17
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 11
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims abstract description 10
- 239000011734 sodium Substances 0.000 claims abstract description 10
- 229910052708 sodium Inorganic materials 0.000 claims abstract description 10
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 9
- 229920002752 Konjac Polymers 0.000 claims abstract description 9
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 9
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 9
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims abstract description 9
- 239000005018 casein Substances 0.000 claims abstract description 9
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims abstract description 9
- 235000021240 caseins Nutrition 0.000 claims abstract description 9
- 239000008103 glucose Substances 0.000 claims abstract description 9
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 9
- 239000000843 powder Substances 0.000 claims abstract description 9
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims abstract description 8
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims abstract description 8
- 230000001804 emulsifying effect Effects 0.000 claims abstract description 6
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 7
- SZYSLWCAWVWFLT-UTGHZIEOSA-N [(2s,3s,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)-2-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxolan-2-yl]methyl octadecanoate Chemical compound O([C@@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@]1(COC(=O)CCCCCCCCCCCCCCCCC)O[C@H](CO)[C@@H](O)[C@@H]1O SZYSLWCAWVWFLT-UTGHZIEOSA-N 0.000 claims description 6
- 239000012153 distilled water Substances 0.000 claims description 6
- 238000004945 emulsification Methods 0.000 claims description 6
- 229940075507 glyceryl monostearate Drugs 0.000 claims description 6
- 150000002664 lycopenes Chemical class 0.000 claims description 6
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 claims description 6
- 238000001694 spray drying Methods 0.000 claims description 6
- 238000009777 vacuum freeze-drying Methods 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 5
- 150000002148 esters Chemical class 0.000 claims description 5
- 239000000839 emulsion Substances 0.000 claims description 3
- 239000012530 fluid Substances 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 239000002131 composite material Substances 0.000 claims description 2
- 240000000111 Saccharum officinarum Species 0.000 claims 1
- 235000007201 Saccharum officinarum Nutrition 0.000 claims 1
- 239000004576 sand Substances 0.000 claims 1
- 239000002994 raw material Substances 0.000 abstract description 10
- 206010028980 Neoplasm Diseases 0.000 abstract description 3
- 239000003963 antioxidant agent Substances 0.000 abstract description 3
- 230000003078 antioxidant effect Effects 0.000 abstract description 3
- 235000006708 antioxidants Nutrition 0.000 abstract description 3
- 201000011510 cancer Diseases 0.000 abstract description 3
- 230000036039 immunity Effects 0.000 abstract description 3
- 239000002904 solvent Substances 0.000 abstract description 3
- 230000003712 anti-aging effect Effects 0.000 abstract description 2
- 210000004185 liver Anatomy 0.000 abstract description 2
- 238000011017 operating method Methods 0.000 abstract description 2
- 229920000858 Cyclodextrin Polymers 0.000 abstract 1
- 239000001116 FEMA 4028 Substances 0.000 abstract 1
- 235000011175 beta-cyclodextrine Nutrition 0.000 abstract 1
- 229960004853 betadex Drugs 0.000 abstract 1
- 238000001035 drying Methods 0.000 abstract 1
- 229960001031 glucose Drugs 0.000 abstract 1
- 229940083542 sodium Drugs 0.000 abstract 1
- 239000003921 oil Substances 0.000 description 12
- 229930006000 Sucrose Natural products 0.000 description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 5
- 239000005720 sucrose Substances 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000002156 mixing Methods 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 241000227653 Lycopersicon Species 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 208000002495 Uterine Neoplasms Diseases 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000003679 aging effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 238000007697 cis-trans-isomerization reaction Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000010525 oxidative degradation reaction Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000001054 red pigment Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 206010046766 uterine cancer Diseases 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
- A23L29/35—Degradation products of starch, e.g. hydrolysates, dextrins; Enzymatically modified starches
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/30—Physical treatment, e.g. electrical or magnetic means, wave energy or irradiation
- A23L5/32—Physical treatment, e.g. electrical or magnetic means, wave energy or irradiation using phonon wave energy, e.g. sound or ultrasonic waves
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention discloses the preparation method of the microcapsules containing lycopene, lycopene is mixed with Seabuckthorm Seed Oil and ganoderma lucidum spore oil, and add compound emulsifying agent and be mixed to get core, using casein sodium, konjaku rubber powder, glucose, beta cyclodextrin, maltodextrin and sodium cellulose glycolate as wall material raw material, the microcapsules containing lycopene are prepared through emulsifying and drying.Liposoluble characteristic of the invention based on lycopene; from Seabuckthorm Seed Oil and ganoderma lucidum spore oil as solvent; core is mixed to get with lycopene; make the microcapsules while have anti-oxidant, anti-aging concurrently, improve the various health care functions such as immunity, protection liver, cancer-resisting; by optimizing wall material raw material; the effective guarantee stability of microcapsules, while there is good water solubility and embedding rate, operating procedure is simple.
Description
Technical field
The invention belongs to food industrial technical field, and in particular to the preparation method of the microcapsules containing lycopene.
Background technology
Lycopene is a kind of natural pigment contained in plant, is primarily present in the ripening fruits of plant of Solanaceae tomato
In.It is most one of the powerful antioxidant being found at present in the plant of nature.Lycopene removes the effect of free radical
Other carotenoid and vitamin E are outclassed, has remarkable result, energy to preventing and treating prostate cancer, lung cancer, breast cancer, uterine cancer etc.
Effectively suppress the diffusion and duplication of cancer cell, prevention cardiovascular and cerebrovascular disease, improve immunity, protect cell DNA from free radical
Infringement, prevents cytopathy, mutation, canceration, also has and promotes cell growth and regeneration, beauty Eradicates wrinkles, maintains skin health, prolongs
Slow aging and other effects, has the title of " plant gold ", is described as " new lovers of 21 century health products ".
Due to having 11 conjugated double bonds and 2 unconjugated double bonds in lycopene molecule so that the stability of lycopene
It is poor, cis-trans isomerization and oxidative degradation can occur under certain condition.Lycopene as physiological activator light,
The factors such as heat, oxygen, pH influence, and oxidation easily occurs and decomposes, so as to lose physiological active functionses and nutriture value to human body
Value, or even cause the serious consequences such as body canceration.In addition, lycopene is fat-soluble pigment, other lipids and non-pole are dissolved in
In property solvent, not soluble in water, therefore, it is difficult to directly add in the water-soluble products such as food, medicine, cosmetics.Lycopene
Unstability and characteristic not soluble in water are limited by very large its application and popularization.Using microcapsules technology to tomato
Red pigment carries out embedding treatment, can improve its availability in functional product, and promote the performance of its physiological function.
Microcapsules refer to a kind of miniature vessel with polymeric shell wall or bag thing, and its size is generally 5~200 μm,
Various shapes, depending on raw material and preparation method.Microcapsules technology is small and seal by solid, liquid or gas entrapment
In capsule, make it only under given conditions just can be with the technology of speed control release.With the development of Micro-Encapsulation Technique,
Lycopene is embedded into the capsule of small closing by choosing appropriate wall material, its active ingredient can be made with stable state
In the presence of, from the interference of external influence factor, and destruction wall material release capsule-core under given conditions.
Application of the microcapsules technology in functional food has become domestic and international study hotspot, but uses microcapsules technology
The research embedded to lycopene is also relatively fewer, therefore urgently further research and improving technology.
The content of the invention
A kind of liposoluble characteristic of the invention based on lycopene, there is provided preparation side of the microcapsules containing lycopene
Method, from Seabuckthorm Seed Oil and ganoderma lucidum spore oil as solvent, core is mixed to get with lycopene, makes the microcapsules while has concurrently
Anti-oxidant, anti-aging, the various health care functions such as immunity, protection liver, cancer-resisting are improved, by optimizing wall material raw material, had
Effect has ensured the stability of microcapsules, while has good water solubility and embedding rate, and operating procedure is simple.
The present invention is realized by following steps：
(1) lycopene is mixed with Seabuckthorm Seed Oil and ganoderma lucidum spore oil, and add HLB value be 8~11 it is compound
Emulsifying agent, core is mixed to get under the conditions of 30~45 DEG C；
(2) using casein sodium, konjaku rubber powder, glucose, beta-schardinger dextrin, maltodextrin and sodium cellulose glycolate as
Raw material, 3~6 times of distilled water are added, wall material is mixed to get under the conditions of 40~50 DEG C；
(3) core and wall material are subjected to high-pressure homogeneous and ultrasonic emulsification and obtain mix emulsion fluid；
(4) microcapsules containing lycopene are obtained using spray drying or vacuum freeze drying.
Every 0.1~0.3g the lycopenes of the present invention are dissolved in 1mL Seabuckthorm Seed Oils and ganoderma lucidum spore oil, wherein Seabuckthorm Seed Oil and
The volume ratio of ganoderma lucidum spore oil is 2~6：1.
The present invention carries out being mixed to get composite emulsifying from sucrose stearate, sucrose oleate, glyceryl monostearate
The mass ratio of agent, compound emulsifying agent and lycopene is 1：8~15.
Wall material raw material of the present invention is by casein sodium, konjaku rubber powder, glucose, beta-schardinger dextrin, maltodextrin and hydroxyl first
Base sodium cellulosate adds water by 5-20%, 20-40%, 10-20%, 5-15%, 20-30%, 5-15% mass percent respectively
It is mixed to prepare.
Core of the present invention and the mass ratio of wall material are 1~5：4~15.
Embodiment
With specific embodiment, the invention will be further described below, but the invention is not limited in these embodiments.
Embodiment 1
0.1g lycopenes are mixed with 1mL Seabuckthorm Seed Oils and ganoderma lucidum spore oil, wherein Seabuckthorm Seed Oil and ganoderma lucidum spore
The weight ratio of seed oil is 6：1, and the compound emulsifying agent that HLB value is 10 is added, compound emulsifying agent is by sucrose stearate, sucrose oil
Acid esters, glyceryl monostearate mix, and the mass ratio of compound emulsifying agent and lycopene is 1：15, mixed under the conditions of 4 DEG C
Conjunction obtains core；Using casein sodium, konjaku rubber powder, glucose, beta-schardinger dextrin, maltodextrin and sodium cellulose glycolate as
Raw material, by 5%, 40%, 10%, 5%, 30%, 10% quality percentage, 5 times of distilled water are added, are mixed under the conditions of 40 DEG C
To wall material；It is 3 in mass ratio by core and wall material：10 are mixed, and mix emulsion fluid is obtained through high-pressure homogeneous and ultrasonic emulsification；
Microcapsules containing lycopene are obtained using spray drying or vacuum freeze drying.
Embodiment 2
0.3g lycopenes are mixed with 1mL Seabuckthorm Seed Oils and ganoderma lucidum spore oil, wherein Seabuckthorm Seed Oil and ganoderma lucidum spore
The weight ratio of seed oil is 3：1, and the compound emulsifying agent that HLB value is 11 is added, compound emulsifying agent is by sucrose stearate, sucrose oil
Acid esters, glyceryl monostearate mix, and the mass ratio of compound emulsifying agent and lycopene is 1：12, mixed under the conditions of 35 DEG C
Conjunction obtains core；Using casein sodium, konjaku rubber powder, glucose, beta-schardinger dextrin, maltodextrin and sodium cellulose glycolate as
Raw material, by 20%, 20%, 20%, 15%, 20%, 5% quality percentage, 4 times of distilled water are added, are mixed under the conditions of 50 DEG C
Obtain wall material；It is 4 in mass ratio by core and wall material：15 are mixed, and mixing and emulsifying is obtained through high-pressure homogeneous and ultrasonic emulsification
Liquid；Microcapsules containing lycopene are obtained using spray drying or vacuum freeze drying.
Embodiment 3
0.2g lycopenes are mixed with 1mL Seabuckthorm Seed Oils and ganoderma lucidum spore oil, wherein Seabuckthorm Seed Oil and ganoderma lucidum spore
The weight ratio of seed oil is 2：1, and the compound emulsifying agent that HLB value is 9 is added, compound emulsifying agent is by sucrose stearate, sucrose oil
Acid esters, glyceryl monostearate mix, and the mass ratio of compound emulsifying agent and lycopene is 1：13, mixed under the conditions of 30 DEG C
Conjunction obtains core；Using casein sodium, konjaku rubber powder, glucose, beta-schardinger dextrin, maltodextrin and sodium cellulose glycolate as
Raw material, by 15%, 30%, 20%, 5%, 15%, 15% quality percentage, 6 times of distilled water are added, are mixed under the conditions of 40 DEG C
Obtain wall material；It is 5 in mass ratio by core and wall material：12 are mixed, and mixing and emulsifying is obtained through high-pressure homogeneous and ultrasonic emulsification
Liquid；Microcapsules containing lycopene are obtained using spray drying or vacuum freeze drying.
Embodiment 4
0.25g lycopenes are mixed with 1mL Seabuckthorm Seed Oils and ganoderma lucidum spore oil, wherein Seabuckthorm Seed Oil and ganoderma lucidum spore
The weight ratio of seed oil is 5：1, and the compound emulsifying agent that HLB value is 8 is added, compound emulsifying agent is by sucrose stearate, sucrose oil
Acid esters, glyceryl monostearate mix, and the mass ratio of compound emulsifying agent and lycopene is 1：9, mixed under the conditions of 45 DEG C
Conjunction obtains core；Using casein sodium, konjaku rubber powder, glucose, beta-schardinger dextrin, maltodextrin and sodium cellulose glycolate as
Raw material, by 10%, 30%, 15%, 10%, 25%, 10% quality percentage, 3 times of distilled water are added, are mixed under the conditions of 50 DEG C
Obtain wall material；It is 1 in mass ratio by core and wall material：4 are mixed, and mixing and emulsifying is obtained through high-pressure homogeneous and ultrasonic emulsification
Liquid；Microcapsules containing lycopene are obtained using spray drying or vacuum freeze drying.
Claims (6)
1. the preparation method of the microcapsules containing lycopene, it is characterised in that comprise the following steps：
(1) lycopene is mixed with Seabuckthorm Seed Oil and ganoderma lucidum spore oil, and adds the composite emulsifying that HLB value is 8~11
Agent, core is mixed to get under the conditions of 30~45 DEG C；
(2) using casein sodium, konjaku rubber powder, glucose, beta-schardinger dextrin, maltodextrin and sodium cellulose glycolate as original
Material, 3~6 times of distilled water are added, wall material is mixed to get under the conditions of 40~50 DEG C；
(3) core and wall material are subjected to high-pressure homogeneous and ultrasonic emulsification and obtain mix emulsion fluid；
(4) microcapsules containing lycopene are obtained using spray drying or vacuum freeze drying.
2. according to the method for claim 1, it is characterised in that every 0.1~0.3g lycopenes are dissolved in 1mL sand in step (1)
In spine seed oil and ganoderma lucidum spore oil, wherein the volume ratio of Seabuckthorm Seed Oil and ganoderma lucidum spore oil is 2~6：1.
3. according to the method for claim 1, it is characterised in that compound emulsifying agent is by sucrose stearate, sugarcane in step (1)
Sugar and oil acid esters and glyceryl monostearate mix.
4. according to the method for claim 1, it is characterised in that the mass ratio of compound emulsifying agent and lycopene in step (1)
For 1：8~15.
5. according to the method for claim 1, it is characterised in that casein sodium in step (2), konjaku rubber powder, glucose,
The mass percent of beta-schardinger dextrin, maltodextrin and sodium cellulose glycolate be respectively 5-20%, 20-40%, 10-20%,
5-15%, 20-30%, 5-15%.
6. according to the method for claim 1, it is characterised in that the core and the mass ratio of wall material are 1~5：4~15.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711211478.9A CN107821923A (en) | 2017-11-28 | 2017-11-28 | The preparation method of microcapsules containing lycopene |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711211478.9A CN107821923A (en) | 2017-11-28 | 2017-11-28 | The preparation method of microcapsules containing lycopene |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107821923A true CN107821923A (en) | 2018-03-23 |
Family
ID=61646169
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201711211478.9A Pending CN107821923A (en) | 2017-11-28 | 2017-11-28 | The preparation method of microcapsules containing lycopene |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107821923A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112618426A (en) * | 2020-06-29 | 2021-04-09 | 昆仑技术研究(广州)有限公司 | Preparation method and application of water-in-oil type white tomato freeze-dried powder |
| CN113730271A (en) * | 2021-10-13 | 2021-12-03 | 齐鲁工业大学 | Edible wolfberry nail polish and preparation method thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101015342A (en) * | 2007-02-08 | 2007-08-15 | 上海交通大学 | Preparation method of lycopersicin microcapsule |
| US20080226772A1 (en) * | 2007-03-13 | 2008-09-18 | Conopco, Inc. D/B/A Unilever | Composite edible product comprising glygeride oil |
| CN101803739A (en) * | 2010-01-20 | 2010-08-18 | 陈恒雷 | Production method of lycopene microcapsule |
| CN102860996A (en) * | 2012-10-18 | 2013-01-09 | 南京中科药业有限公司 | Method for preparing lycoypene microcapsule |
| CN106417598A (en) * | 2016-09-09 | 2017-02-22 | 嘉必优生物技术（武汉）股份有限公司 | Preparation method of lycopene-containing microcapsules |
-
2017
- 2017-11-28 CN CN201711211478.9A patent/CN107821923A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101015342A (en) * | 2007-02-08 | 2007-08-15 | 上海交通大学 | Preparation method of lycopersicin microcapsule |
| US20080226772A1 (en) * | 2007-03-13 | 2008-09-18 | Conopco, Inc. D/B/A Unilever | Composite edible product comprising glygeride oil |
| CN101803739A (en) * | 2010-01-20 | 2010-08-18 | 陈恒雷 | Production method of lycopene microcapsule |
| CN102860996A (en) * | 2012-10-18 | 2013-01-09 | 南京中科药业有限公司 | Method for preparing lycoypene microcapsule |
| CN106417598A (en) * | 2016-09-09 | 2017-02-22 | 嘉必优生物技术（武汉）股份有限公司 | Preparation method of lycopene-containing microcapsules |
Non-Patent Citations (1)
| Title |
|---|
| 孟宪军，等: "《食品工艺学概论》", 31 May 2006, 中国农业出版社 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112618426A (en) * | 2020-06-29 | 2021-04-09 | 昆仑技术研究(广州)有限公司 | Preparation method and application of water-in-oil type white tomato freeze-dried powder |
| CN113730271A (en) * | 2021-10-13 | 2021-12-03 | 齐鲁工业大学 | Edible wolfberry nail polish and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ribeiro et al. | Microencapsulation of natural dyes with biopolymers for application in food: A review | |
| Yuan et al. | Shellac: A promising natural polymer in the food industry | |
| de Freitas Santos et al. | Microencapsulation of carotenoid-rich materials: A review | |
| Saini et al. | An updated review on use of tomato pomace and crustacean processing waste to recover commercially vital carotenoids | |
| Dedhia et al. | Food polysaccharides: A review on emerging microbial sources, bioactivities, nanoformulations and safety considerations | |
| Ashraf et al. | Technological advancement in the processing of lycopene: a review | |
| Dajic Stevanovic et al. | Natural macromolecules as carriers for essential oils: From extraction to biomedical application | |
| CN107981355A (en) | A kind of preparation method of lycopene microcapsule | |
| CN101444495B (en) | Vitamin E microcapsule preparation method | |
| Noore et al. | Novel bioactive extraction and nano-encapsulation | |
| Zhou et al. | Stability application and research of astaxanthin integrated into food | |
| CN109820837A (en) | A kind of microcapsules of the ester containing natural astaxanthin and preparation method thereof | |
| Rodríguez-Sifuentes et al. | Importance of downstream processing of natural astaxanthin for pharmaceutical application | |
| Santos et al. | Recent advances in the encapsulation of bioactive ingredients using galactomannans-based as delivery systems | |
| Zhao et al. | Research progress of starch as microencapsulated wall material | |
| CN107821923A (en) | The preparation method of microcapsules containing lycopene | |
| CN108157942B (en) | Method for embedding hydroxytyrosol by spraying gelatinized ginkgo starch | |
| Culas et al. | Recent advances in encapsulation techniques for cinnamon bioactive compounds: A review on stability, effectiveness, and potential applications | |
| Weiss et al. | Utilization of hydrocolloids for the stabilization of pigments from natural sources | |
| CN104774483B (en) | Preparation method of micro-nano-corn yellow pigment | |
| CN109480285A (en) | A kind of haematococcus pluvialis soft capsule | |
| Santos-Sánchez et al. | Astaxanthin and its Formulations as Potent Oxidative Stress Inhibitors. | |
| Roy et al. | Important carotenoids derived from marine biomass: Extraction, stabilization, and potentiality in food, cosmetics, and pharmaceutical application | |
| Aslam et al. | Stability of carotenoids | |
| de Carvalho et al. | In situ extraction/encapsulation of olive leaves antioxidants in zein for improved oxidative stability of edible oils |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180323 |
|
| RJ01 | Rejection of invention patent application after publication |